What is BioCatch?
Founded in 2011 and headquartered in Israel, BioCatch operates at the forefront of cybersecurity by developing sophisticated behavioral biometric profiles of online users. This technology is instrumental in recognizing a wide spectrum of human and non-human cybersecurity threats, offering advanced protection for digital environments. The company's platform analyzes user behavior patterns to detect anomalies and potential breaches, providing a crucial layer of defense against evolving cyber risks. BioCatch's focus on behavioral biometrics positions it as a key player in the identity verification and fraud prevention sector.
How much funding has BioCatch raised?
BioCatch has raised a total of $213.1M across 6 funding rounds:
Other Financing Round
$600K
Other Financing Round
$1M
Unspecified
$6.5M
Series A
$10M
Series B
$30M
Series C
$165M
Other Financing Round (2012): $600K with participation from JANVEST Capital Partners
Other Financing Round (2013): $1M led by JANVEST Capital Partners
Unspecified (2014): $6.5M supported by OurCrowd and JANVEST Technologies
Series A (2014): $10M featuring Blumberg Capital and OurCrowd
Series B (2018): $30M backed by JANVEST Capital Partners, Kreos Capital, American Express, OurCrowd, and CreditEase
Series C (2020): $165M with participation from Bain Capital Tech Opportunities, HSBC, Citibank, National Australia Bank, CreditEase, Barclays, American Express, and Maverick ventures
Key Investors in BioCatch
HSBC
HSBC is a global financial institution that provides a wide range of banking and financial services. Its participation in BioCatch's funding round suggests a strategic interest in the cybersecurity sector and its implications for financial services.
Citibank
Citibank, a major global financial services provider, has invested in BioCatch, indicating a focus on enhancing security measures within the financial technology space and supporting innovative cybersecurity solutions.
American Express
American Express, a global financial services company, has backed BioCatch, highlighting its commitment to robust cybersecurity and fraud prevention technologies essential for its payment and travel services.
What's next for BioCatch?
The substantial enterprise-level funding secured by BioCatch indicates a strong trajectory for scaling its operations and further innovating its behavioral biometric platform. This capital infusion is expected to fuel product development, enhance market penetration, and potentially support strategic acquisitions. As the company continues to mature, it is well-positioned to capitalize on the increasing demand for advanced cybersecurity solutions, particularly those that leverage AI and machine learning for threat detection. The consistent backing from prominent financial institutions and venture capital firms suggests confidence in BioCatch's business model and its capacity to address critical security challenges in the digital age.
See full BioCatch company page
